Catioma 10g Korean Pharma skin cream for inflammation, psoriasis, atopic dermatitis allergic

Dosage form Box x 10g
Specifications Mometason Furoat
Ingredient Korea Pharma Co., Ltd.

Ingredient

Thành phần cho 10g

Composition information	Content
Mometason Furoat	10mg

Uses

Indications

Mometason Furoat topical cream 0.1% KL/KL is indicated to treat inflammatory and itching manifestations in psoriasis (except for psoriasis psoriasis) and atopic dermatitis.

This drug is used for adults and children over 6 years old.

Pharmacokology

Pharmacological effects: Located corticosteroids.

Code ATC: D07AC13

Mometason Furoat shows anti -inflammatory and anti -psoriasis activity on animal prediction models.

After causing inflammation with triple bean oil (croton oil) in mice, Mometason shows the potential equivalent to Betamethason Valerat after single dose and about 8 times after 5 doses of use.

In the mouse, Mometason shows the potential of approximately twice as much as Betamethason Valerat in reducing the symptoms of M. Ovalis skin epidermal disease (i.e., anti -psoriasis activity) after 14 doses of use.

Dynamic pharmacokinetics

Pharmacokinetics studies have shown the whole body absorption after using topical cream of Mometason Furoat 0.1% KL/KL is very small, about 0.4% of the dose in humans, mostly excreted within 72 hours after drug use. The determination of metabolites is not feasible because they are only present in small amounts in plasma, feces and urine.

Before taking Catioma 10g Korean Pharma skin cream for inflammation, psoriasis, atopic dermatitis allergic

How to use

Apply to the skin.

Dosage

Adults, including elderly patients, adolescents and children aged 6 and older: Apply a thin layer of cream on the skin of Mometason Furoat 0.1% KL/KL to the sick once daily skin. A unit calculated by the knuckles (limited to the index finger of the adult to the first fold) is enough to cover a double area of the hands of adults.

Recommendation for the use of corticosteroids with less potential when patients have clinical improvement.

Do not use topical creams of 0.1% KL/KL Mometason Furoat for a long time (over 3 weeks) or on a large scale (over 20% of the body surface area). In children only use up to 10% of the body surface area.

In case of using corticosteroids for children in children 6 years of age or older or when applied on the face, the minimum amount of use must be limited to an effective treatment regime and the treatment time does not exceed 5 days.

Children under 6 years old: Mometason Furoat topical cream 0.1% KL/KL is not recommended for use because there is no full data on safety in children under 6 years old.

What to do when overdose?

If the actual inhibition of the-TY-TTT-ty-ttt shaft is detected, the drug should be discontinued, reducing the frequency of use or replacement with a less potential corticoid. Actively monitor for timely measures.

The steroid concentration of each tube is not too high to prevent less or not toxicity occurs when accidentally swallowed.

If the symptoms appear, it is advisable to stop using the topical cream of Mometason Furoat 0.1% KL/KL and appropriate treatment.

What to do when forgetting a dose?

Side Effects

Unwanted effects are recorded when using Mometason Furoat classified by organ systems and frequency as follows: Very common (1/10); Common (> = 1/100, = 1/1,000, = 1/10,000,

infection and parasitic infection

Unknown: infections, boils.

Very rare: folliculitis.

Unknown: Perception.

Very rare: burning sensation.

Unknown: Contact dermatitis, skin pigmentation, hair, skin scars, acne dermatitis, skincare disorders.

Unknown: Pain, local reaction. The body is larger than the body weight.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

sensitive to Mometason Furoat, other corticosteroids or any ingredients of the drug.

Patients with red acne, acne on the face, dermatitis around the mouth, itching around the anus and genital organs, diaper rash, bacterial infections (such as impetigo), virus infections (such as herpes simplex, herpes zoster and chickenpox), parasite and fungal infection (such as Candida or Dermatophytes). Chickenpox, tuberculosis, syphilis or response after vaccination.

Do not use 0.1% KL/KL 0.1% Mometason Furoat on wounds or ulcerative skin.

Be cautious when used

The whole body absorption of topical corticosteroids can cause inhibitor to restore the hypothalamus - pituitary - adrenal glands (HD -TY -TTT). Manifestations of Cushing syndrome, hyperglycemia, and urinary tract may also appear in some patients due to corticoid body absorption when treated on the spot.

Patients use steroids to a large skin surface area or bandaged skin areas that need to be used by steroids to a large skin surface area or icy skin areas that need to be periodically assessed to inhibit the-TY-TTT-TTT-TTT-TY-TTT axis inhibitors.

If the inhibition of the-TY-TTT activity is recorded, the frequency of use or replacement should be reduced by a less active corticoid. The rehabilitation of the-Ty-TTT-TTT activity is usually noted after the corticosteroids.

Pediatric patients may be more sensitive to toxicity from the equivalent dosage due to the larger skin surface/body surface ratio.

If the symptoms appear, it is advisable to stop using the topical cream of Mometason Furoat 0.1% KL/KL and appropriate treatment.

Only use skin drugs. Avoid contact with eyes.

Do not use Mometason Furoat topical cream 0.1% KL/KL in the treatment of dermatitis in the skin wrapped in children.

Do not use other corticosteroid products along with 0.1% KL/KL 0.1% Mometason Furoat skin without advice from a doctor or pharmacist.

excipients:

0.1% KL/KL 0.1% KL/KL Mometason Furoat cream that contains propylene glycol that can cause skin irritation.

The ingredient Stearyl alcohol in the cream can cause local reactions on the skin (such as contact dermatitis).

The effect of the drug on driving and operating machinery

The drug does not affect the ability to drive and operate machinery.

Use drugs for women during pregnancy and lactation

Pregnant women:

corticoids have been shown to cause teratogenic animals when used with relatively low dosage systems. Some corticosteroids have been shown to be teratogenic after use on animal skin in the laboratory.

There is no adequate research and well controlled the teratogenic effects from local corticosteroids when used in pregnant women. Therefore, local corticosteroids should be used during pregnancy if they have fully considered the potential and risks for the fetus.

breastfeeding women:

corticosteroids are excreted into breast milk and can prevent growth, affect endogenous corticosteroids, or cause other unwanted effects. It is not known whether the use of topical corticosteroids can lead to enough body absorption to appear corticosteroids in breast milk or not. Should be cautious when using Mometason Furoat topical cream 0.1% KL/KL in breastfeeding women.

Medicinal interaction

Using Mometason Furoat topical cream 0.1% KL/KL along with other corticosteroids may increase the risk of inhibiting hill -pito -glands - adrenal glands.

Storage

Leave a cool place, avoid light, temperatures below 30⁰C.

To be out of reach of children, read the instructions carefully before use.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.